Total Funding
14
Total FundingSeries B raised
Growth Score
pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Adnavance Technologies develops direct detection molecular diagnostic tests for medical applications.
About the Company
Adnavance Technologies is an early-stage developer of direct detection molecular diagnostic tests. The company's patented and ultra-sensitive metalized-DNA (M-DNA™) technology may eliminate the need for amplification for a large number of these tests. This technology provides many significant advantages over existing methods, including ease of
use, time to result and cost. The platform is simple and inexpensive and is expected to receive FDA approval for use by any laboratory.
